TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 50, Issue 4, Pages 485-494
Publisher
Informa UK Limited
Online
2015-01-23
DOI
10.3109/00365521.2014.980318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- O-0003 * NAPOLI-1: RANDOMIZED PHASE 3 STUDY OF MM-398 (NAL-IRI), WITH OR WITHOUT 5-FLUOROURACIL AND LEUCOVORIN, VERSUS 5-FLUOROURACIL AND LEUCOVORIN, IN METASTATIC PANCREATIC CANCER PROGRESSED ON OR FOLLOWING GEMCITABINE-BASED THERAPY
- (2014) D. Von Hoff et al. ANNALS OF ONCOLOGY
- A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
- (2014) T S Maughan et al. BRITISH JOURNAL OF CANCER
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development
- (2014) Yasuni Nakanuma et al. Journal of Hepato-Biliary-Pancreatic Sciences
- A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma
- (2013) D. P. S. Sohal et al. ANNALS OF ONCOLOGY
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- (2013) A H Ko et al. BRITISH JOURNAL OF CANCER
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
- (2013) Jie Shen et al. Journal of Translational Medicine
- Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
- (2013) David Hersi Smith et al. PLoS One
- Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer
- (2013) Sune Boris Nygård et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
- (2013) Thierry Conroy et al. Current Oncology Reports
- Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development
- (2013) Jan Stenvang et al. Frontiers in Oncology
- Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) T. Seufferlein et al. ANNALS OF ONCOLOGY
- FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
- (2012) Alberto Zaniboni et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules
- (2012) Chihiro Gandou et al. HUMAN PATHOLOGY
- Topoisomerase 1(TOP1 ) gene copy number in stage III colorectal cancer patients and its relation to prognosis
- (2012) Maria Unni Rømer et al. Molecular Oncology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) F. Eckel et al. ANNALS OF ONCOLOGY
- Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer
- (2011) Moon Jae Chung et al. CHEMOTHERAPY
- Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- (2011) Peter C. Thuss-Patience et al. EUROPEAN JOURNAL OF CANCER
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- TOP1gene copy numbers in colorectal cancer samples and cell lines and their association toin vitrodrug sensitivity
- (2011) Maria Unni Rømer et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall Survival
- (2010) Suzanne C. Schiffman et al. ANNALS OF SURGICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract
- (2010) Niki Karachaliou et al. ONCOLOGY
- Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy
- (2009) Ioannis Kostopoulos et al. BMC CANCER
- A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- (2009) C Yoo et al. BRITISH JOURNAL OF CANCER
- Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer
- (2009) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
- Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer
- (2009) B. Neri et al. ONCOLOGY RESEARCH
- Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
- (2008) Seong Yoon Yi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
- (2008) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now